Published in Circulation on April 21, 1998
The effect of hypohydration on endothelial function in young healthy adults. Eur J Nutr (2016) 1.93
Regular endurance exercise induces expansive arterial remodelling in the trained limbs of healthy men. J Physiol (2001) 1.62
Fabrication and in vitro deployment of a laser-activated shape memory polymer vascular stent. Biomed Eng Online (2007) 0.91
Fibrinogen and left ventricular myocardial systolic function: The Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J (2010) 0.87
Xuezhikang, extract of red yeast rice, improved abnormal hemorheology, suppressed caveolin-1 and increased eNOS expression in atherosclerotic rats. PLoS One (2013) 0.83
Sex and limb-specific ischemic reperfusion and vascular reactivity. Am J Physiol Heart Circ Physiol (2008) 0.80
Carotid intima media thickness as a measure of cardiovascular disease burden in nigerian africans with hypertension and diabetes mellitus. Int J Vasc Med (2011) 0.79
Associations of D-dimer and von Willebrand factor with atherosclerosis in Japanese and white men. Acta Cardiol (2010) 0.78
The role of hemorheological factors in cardiovascular medicine. Clin Hemorheol Microcirc (2014) 0.77
Association of hyperviscosity and subclinical atherosclerosis in obese schoolchildren. Eur J Pediatr (2005) 0.77
Effects of feeding periods of high cholesterol and saturated fat diet on blood biochemistry and hydroxyproline fractions in rabbits. Bioinform Biol Insights (2008) 0.75
The changes in various hydroxyproline fractions in aortic tissue of rabbits are closely related to the progression of atherosclerosis. Lipids Health Dis (2010) 0.75
rHuEPO hyporesponsiveness and related high dosages are associated with hyperviscosity in maintenance hemodialysis patients. ScientificWorldJournal (2013) 0.75
Hemorheological profiles of subjects with prehypertension. Hypertens Res (2016) 0.75
Rosuvastatin Reduces Blood Viscosity in Patients with Acute Coronary Syndrome. Korean Circ J (2016) 0.75
Hemorheological Alteration in Patients Clinically Diagnosed with Chronic Liver Diseases. J Korean Med Sci (2016) 0.75
Antithrombotic treatment and atrial fibrillation. BMJ (1992) 5.33
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med (2000) 3.90
Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation (2002) 3.63
The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol (1992) 3.00
Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke (1999) 2.89
Submissiveness and protection from coronary heart disease in the general population: Edinburgh Artery Study. Lancet (1997) 2.76
von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J (2002) 2.66
Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol (2003) 2.63
Audit reviewed: does feedback on performance change clinical behaviour? J R Coll Physicians Lond (1985) 2.62
Implementation of guidelines for the use of skull radiographs in patients with head injuries. Lancet (1984) 2.60
Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ (1996) 2.58
Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health (1999) 2.48
Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation (2001) 2.43
Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. J Clin Epidemiol (1990) 2.43
Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Circulation (1996) 2.32
Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J (2000) 2.30
Multicentre trial of four strategies to reduce use of a radiological test. Lancet (1986) 2.26
Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol (1996) 2.25
The effect of long saphenous vein stripping on deep venous reflux. Eur J Vasc Endovasc Surg (2004) 2.17
Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur Heart J (1999) 2.08
Tissue plasminogen activator and leucocyte elastase as predictors of cardiovascular events in subjects with angina pectoris: Edinburgh Artery Study. Eur Heart J (2000) 2.08
Acute exercise and markers of endothelial injury in peripheral arterial disease. Eur J Vasc Endovasc Surg (1997) 2.07
Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study. Diabetologia (2011) 2.06
Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med (2008) 2.06
Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol (2001) 1.96
Urban air pollution and cardiopulmonary ill health: a 14.5 year time series study. Occup Environ Med (1998) 1.85
ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation. BMJ (1996) 1.85
Trial of strategy for reducing the use of laboratory tests. Br Med J (Clin Res Ed) (1986) 1.82
Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol (1997) 1.72
A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease. J Thromb Haemost (2007) 1.69
Smoking, atherosclerosis and risk of abdominal aortic aneurysm. Eur Heart J (1997) 1.68
Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus. Br Med J (Clin Res Ed) (1986) 1.64
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.63
Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. Eur Heart J (1997) 1.60
The relationship between blood viscosity and blood pressure in a random sample of the population aged 55 to 74 years. Eur Heart J (1993) 1.60
Medical audit cycle. A review of methods and research in clinical practice. Med Educ (1982) 1.59
Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. Am Heart J (1996) 1.59
The relationship between abdominal aortic aneurysm wall compliance, maximum diameter and growth rate. Cardiovasc Surg (1999) 1.47
Surgical manpower, beds and output in the NHS: 1967-1977. Br J Surg (1983) 1.47
The effect of long saphenous vein stripping on quality of life. J Vasc Surg (2002) 1.47
Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease. Diabetologia (2004) 1.46
Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease. The Edinburgh Artery Study. Stroke (1997) 1.45
Tissue plasminogen activator inhibition in diabetes mellitus. Diabetes Care (1989) 1.45
Association of fibrinolytic tests with outcome of acute upper-gastrointestinal-tract bleeding. Lancet (1993) 1.45
Purchasing vascular services. Independent advice needed. BMJ (1994) 1.45
Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet (1992) 1.44
Saphenous surgery does not correct perforator incompetence in the presence of deep venous reflux. J Vasc Surg (1998) 1.43
Fetal corticotrophin-releasing hormone mRNA, but not phosphatidylserine-exposing microparticles, in maternal plasma are associated with factor VII activity in pre-eclampsia. J Thromb Haemost (2007) 1.43
Relation between extent of coronary artery disease and blood viscosity. Br Med J (1980) 1.42
Comparison of venous reflux in the affected and non-affected leg in patients with unilateral venous ulceration. Br J Surg (1996) 1.41
Changing management of pyogenic liver abscess. Br J Surg (1996) 1.40
Popliteal vein reflux reduces the healing of chronic venous ulcer. Br J Surg (1998) 1.39
In vivo measurements of fibrin formation and fibrinolysis in operable breast cancer. Thromb Haemost (1989) 1.39
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J (1995) 1.38
Blood rheology in vitro and in vivo. Baillieres Clin Haematol (1987) 1.36
Dental disease, fibrinogen and white cell count; links with myocardial infarction? Scott Med J (1993) 1.36
Possible impact of audit on chest X-ray requests from surgical wards. Lancet (1983) 1.35
Increased fetal hemoglobin in insulin-treated diabetes mellitus contributes to the imprecision of glycohemoglobin measurements. Clin Chem (1993) 1.35
Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion. Br J Ophthalmol (1983) 1.34
Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem (2000) 1.34
Relation of atrial fibrillation and high haematocrit to mortality in acute stroke. Lancet (1983) 1.34
Containing the use of diagnostic tests. Br Med J (Clin Res Ed) (1985) 1.33
Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol (1996) 1.29
The effects of age and cigarette-smoking on blood and plasma viscosity in men. Scott Med J (1980) 1.28
Compliance with the Royal College of Radiologists' guidelines on the use of pre-operative chest radiographs. Clin Radiol (1987) 1.28
How periodontal disease may contribute to cardiovascular disease. Periodontol 2000 (2000) 1.26
What are the symptoms of varicose veins? Edinburgh vein study cross sectional population survey. BMJ (1999) 1.25
Prevalence of venous reflux in the general population on duplex scanning: the Edinburgh vein study. J Vasc Surg (1998) 1.25
Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. Eur Heart J (2004) 1.24
Blood rheology in arterial disease. Clin Sci (Lond) (1986) 1.23
Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation (1993) 1.21
Fatal retroperitoneal haemorrhage complicating anticoagulant therapy. Postgrad Med J (1979) 1.21
Risk factors for postoperative death following elective surgical repair of abdominal aortic aneurysm: results from the UK Small Aneurysm Trial. On behalf of the UK Small Aneurysm Trial participants. Br J Surg (2000) 1.21
HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA. Lancet (1984) 1.20
Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol (1999) 1.17
Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol (1997) 1.17
Epidemiology of varicose veins. A review. Int Angiol (1994) 1.17